The current stock price of EXOZ is 12.47 USD. In the past month the price decreased by -22.06%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.33 | 406.30B | ||
| AMGN | AMGEN INC | 15.27 | 179.83B | ||
| GILD | GILEAD SCIENCES INC | 15.34 | 155.92B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.67 | 117.47B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.41 | 82.37B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 785.67 | 52.94B | ||
| INSM | INSMED INC | N/A | 37.84B | ||
| NTRA | NATERA INC | N/A | 32.51B | ||
| BIIB | BIOGEN INC | 10.53 | 25.87B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.5 | 22.16B | ||
| INCY | INCYTE CORP | 15.64 | 19.72B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.27B |
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
EXOZYMES INC
750 Royal Oaks Dr
Monrovia California CALIFORNIA US
Employees: 31
Phone: 16264151488
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
The current stock price of EXOZ is 12.47 USD. The price increased by 0.65% in the last trading session.
EXOZ does not pay a dividend.
EXOZ has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
EXOZYMES INC (EXOZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.76).
EXOZYMES INC (EXOZ) will report earnings on 2026-03-31.
You can find the ownership structure of EXOZYMES INC (EXOZ) on the Ownership tab.
ChartMill assigns a fundamental rating of 1 / 10 to EXOZ. The financial health of EXOZ is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months EXOZ reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS decreased by -256.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -108.04% | ||
| ROE | -155.17% | ||
| Debt/Equity | 0.01 |